About
Cadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation. The company was founded in 2022 and is headquartered in Ponte Vedra Beach, Florida.
Team & affiliation
Founders: [object Object].
Region context
Cadrenal Therapeutics is the only Biopharma company we track in undefined, based in Ponte Vedra Beach — one of 6 across Virginia.